The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells

Diabetologia

Volumn 55, Issue 5, 2012, Pages 1514-1525

  Rittig, K ^a   Dolderer, J H ^a   Balletshofer, B ^a   MacHann, J ^a   Schick, F ^a   Meile, T ^a   Kuper M ^a   Stock, U A ^a   Staiger, H ^a   MacHicao, F ^a   Schaller, H E ^a   Konigsrainer A ^a   Haring H U ^a   Siegel Axel, D I ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adipocytes; Angiogenic factors; Atherosclerotic plaque; HGF; Insulin sensitivity; Perivascular tissue; Pre adipocytes

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SCATTER FACTOR; SERPIN E1; SOMATOMEDIN BINDING PROTEIN 3; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CELL GROWTH; CELL MATURATION; CELL SECRETION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MASS; MONOCULTURE; PERIVASCULAR FAT CELL; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER; SUBCUTANEOUS FAT CELL; VISCERAL FAT CELL;

ABDOMINAL FAT; ADIPOCYTES; ADULT; AGED; ANGIOGENESIS INDUCING AGENTS; ANGIOGENIC PROTEINS; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; SUBCUTANEOUS FAT; YOUNG ADULT;

EID: 84862564234     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2481-9     Document Type: Article

References (47)

1. Gallagher EJ, Leroith D, Karnieli E (2010) Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med 77: 511-523
2. Iozzo P (2009) Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue. Diabetes Care 32(Suppl 2): S168-S173
3. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887
4. Wozniak SE, Gee LL, Wachtel MS, Frezza EE (2009) Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 54: 1847-1856
5. Hauner H (2005) Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64: 163-169
6. Ohman MK, Shen Y, Obimba CI et al (2008) Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117: 798-805
7. Mazurek T, Zhang L, Zalewski A et al (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108: 2460-2466
8. Ouwens DM, Sell H, Greulich S, Eckel J (2010) The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med 14: 223-2234
9. Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R (2007) Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J Physiol Pharmacol 58: 591-610
10. Rajsheker S, Manka D, Blomkalns AL, Chatterjee TK, Stoll LL, Weintraub NL (2010) Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol 10: 191-196
11. Rittig K, Staib K, Machann J et al (2008) Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia 51: 2093-2099
12. Yudkin JS, Eringa E, Stehouwer CD (2005) "Vasocrine" signaling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365: 1817-1820
13. Ichiki T (2010) Perivascular adipose tissue, a Janus-faced regulator of vascular function. Circ J 74: 1300-1301
14. Mahabadi AA, Reinsch N, Lehmann N et al (2010) Association of pericoronary fat volume with atherosclerotic plaque burden in the underlying coronary artery: a segment analysis. Atherosclerosis 211: 195-199
15. Silaghi AC, Poant? L, Valea A, Pais R, Silaghi H (2011) Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction? Med Ultrason 13: 15-20
16. Sicari R, Sironi AM, Petz R et al (2011) Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study. J Am Soc Echocardiogr 24: 1156-1162
17. Silaghi A, Piercecchi-Marti MD, Grino M et al (2008) Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity 16: 2424-2430
18. Hausman GJ, Richardson RL (2004) Adipose tissue angiogenesis. J Anim Sci 82: 925-934
19. Crandall DL, Hausman GJ, Kral JG (1997) A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4: 211-232
20. Chatterjee TK, Stoll LL, Denning GM et al (2009) Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 104: 541-549
21. Kwon HM, Sangiorgi G, Ritman EL et al (1998) Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 101: 1551-1556
22. Mulligan-Kehoe MJ (2010) The vasa vasorum in diseased and nondiseased arteries. Am J Physiol Heart Circ Physiol 298: H295-H305
23. Engeli S (2005) Is there a pathophysiological role for perivascular adipocytes? Am J Physiol Heart Circ Physiol 289: H1794-H1795
24. Henrichot E, Juge-Aubry CE, Pernin A et al (2005) Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25: 2594-2599
25. Schling P, Mallow H, Trindl A, Loffler G (1999) Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord 23: 336-341
26. Van RL, Bayliss CE, Roncari DA (1976) Cytological and enzymological characterization of adult human adipocyte precursors in culture. J Clin Invest 58: 699-704
27. Axel DI, Brehm BR, Wolburg-Buchholz K, Betz EL, Köveker G, Karsch KR (1996) Induction of cell-rich and lipid-rich plaques in a transfilter coculture system with human vascular cells. J Vasc Res 33: 327-339
28. Schafer S, Kantartzis K, Machann J et al (2007) Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest 37: 535-543
29. Stefan N, Hennige AM, Staiger H et al (2007) High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30: 1173-1178
30. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ (2002) Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 99: 10730-10735
31. Lijnen HR (2008) Angiogenesis and obesity. Cardiovasc Res 1 (78): 286-293
32. Cao Y (2007) Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117: 362-2368
33. Lai N, Jayaraman A, Lee K (2009) Enhanced proliferation of human umbilical vein endothelial cells and differentiation of 3T3-L1 adipocytes in coculture. Tissue Eng Part A 15: 1053-1061
34. Saiki A, Watanabe F, Murano T, Miyashita Y, Shirai K (2006) Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro. Int J Obes (Lond) 30: 1676-1684
35. Aoki S, Toda S, Sakemi T, Sugihara H (2003) Coculture of endothelial cells and mature adipocytes actively promotes immature preadipocyte development in vitro. Cell Struct Funct 28: 55-60
36. Poissonnet CM, Burdi AR, Bookstein FL (1983) Growth and development of human adipose tissue during early gestation. Early Hum Dev 8: 1-11
37. Frye CA, Wu X, Patrick CW (2005) Microvascular endothelial cells sustain preadipocyte viability under hypoxic conditions. In Vitro Cell Dev Biol Anim 41: 160-164
38. Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH (2010) Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb 17: 115-130
39. Di Stefano R, Felice F, Balbarini A (2009) Angiogenesis as risk factor for plaque vulnerability. Curr Pharm Des 15: 1095-1106
40. Nakagami H, Kaneda Y, Ogihara T, Morishita R (2005) Hepatocyte growth factor as potential cardiovascular therapy. Expert Rev Cardiovasc Ther 3: 513-519
41. Funakoshi H, Nakamura T (2003) Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 327: 1-23
42. Bell LN, Cai L, Johnstone BH, Traktuev DO, March KL, Considine RV (2008) A central role for hepatocyte growth factor in adipose tissue angiogenesis. Am J Physiol Endocrinol Metab 294: E336-E344
43. Rehman J, Considine RV, Bovenkerk JE et al (2003) Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 41: 1408-1413
44. Chowdhury M, Ghosh J, Slevin M, Smyth JV, Alexander MY, Serracino-Inglott F (2010) A comparative study of carotid atherosclerotic plaque microvessel density and angiogenic growth factor expression in symptomatic versus asymptomatic patients. Eur J Vasc Endovasc Surg 39: 388-395
45. Liu Y, Wilkinson FL, Kirton JP et al (2007) Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development. J Pathol 212: 12-19
46. Orr AW, Hastings NE, Blackman BR, Wamhoff BR (2010) Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res 47: 168-180
47. Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, Fox CS (2010) Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Therosclerosis 210: 656-661